NASDAQ Rheumatology Market News

Axsome Therapeutics Initiates Phase 3 Study of AXS-02 for Knee Osteoarthritis Associated with Bone Marrow Lesions

First Patient Enrolled in the COAST-1 StudyNon-Opioid, Oral, Targeted, Potentially First-in-Class Mechanism for PainNovel ...

Apricus Reports Top-Line Phase 2b Data for Fispemifene in Symptomatic Secondary Hypogonadism

Fispemifene Failed to Achieve Statistical Significance in Key Clinical Benefit Endpoints Despite Increase in ...

Risk of Work Time Loss Almost Double for Osteoarthritis Sufferers

TORONTO, March 24, 2016 (GLOBE NEWSWIRE) -- Osteoarthritis (OA) sufferers have almost twice the ...

TSI Healthcare Named Top EHR for Rheumatology in Black Book Survey

CHAPEL HILL, N.C., March 08, 2016 (GLOBE NEWSWIRE) -- TSI Healthcare, a national leader ...

Apricus Biosciences to Present at the 28th Annual ROTH Conference

SAN DIEGO, March 08, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

Apricus Biosciences Closes $10 Million Registered Direct Offering

SAN DIEGO, March 04, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

Apricus Biosciences to Present at the Cowen and Company 36th Annual Health Care Conference

SAN DIEGO, March 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...